Skip to main content
Premium Trial:

Request an Annual Quote

We're Seeking Consensus from a Ouija Board and a Magic 8 Ball

Daniel MacArthur at Genetic Future has a blog post listing what he considers "some of the major trends that will play out in the human genomics field in 2009 - both in terms of research outcomes, and shifts in the rapidly-evolving consumer genomics industry," he writes. Among them: increased focus on rare variants in common diseases; "a proliferation of new companies attempting to gain a share of the personal genomics market, most of whom will sink rapidly into obscurity"; and no way, he says, that a complete genome sequence will be offered for a retail price of less than $1,000.

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.